nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—Piroxicam—Oxcarbazepine—epilepsy syndrome	0.215	1	CrCrCtD
Meloxicam—systemic lupus erythematosus—Pregabalin—epilepsy syndrome	0.176	0.535	CpDpCtD
Meloxicam—systemic lupus erythematosus—Gabapentin—epilepsy syndrome	0.101	0.307	CpDpCtD
Meloxicam—PTGS2—epilepsy syndrome	0.0697	1	CbGaD
Meloxicam—rheumatoid arthritis—Gabapentin—epilepsy syndrome	0.0523	0.158	CpDpCtD
Meloxicam—CYP2C8—Trimethadione—epilepsy syndrome	0.0147	0.0605	CbGbCtD
Meloxicam—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0138	0.0569	CbGbCtD
Meloxicam—PTGS1—Diazepam—epilepsy syndrome	0.013	0.0537	CbGbCtD
Meloxicam—PTGS1—Valproic Acid—epilepsy syndrome	0.0103	0.0423	CbGbCtD
Meloxicam—CYP2C9—Trimethadione—epilepsy syndrome	0.0103	0.0422	CbGbCtD
Meloxicam—CYP2C8—Carbamazepine—epilepsy syndrome	0.00994	0.0409	CbGbCtD
Meloxicam—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00965	0.0397	CbGbCtD
Meloxicam—CYP2C8—Primidone—epilepsy syndrome	0.00928	0.0382	CbGbCtD
Meloxicam—CYP2C8—Phenytoin—epilepsy syndrome	0.00891	0.0367	CbGbCtD
Meloxicam—CYP2C8—Propofol—epilepsy syndrome	0.00831	0.0342	CbGbCtD
Meloxicam—CYP2C8—Phenobarbital—epilepsy syndrome	0.00794	0.0327	CbGbCtD
Meloxicam—CYP2C8—Diazepam—epilepsy syndrome	0.00753	0.031	CbGbCtD
Meloxicam—CYP2C9—Carbamazepine—epilepsy syndrome	0.00693	0.0285	CbGbCtD
Meloxicam—CYP2C9—Primidone—epilepsy syndrome	0.00647	0.0266	CbGbCtD
Meloxicam—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00642	0.0264	CbGbCtD
Meloxicam—CYP2C9—Phenytoin—epilepsy syndrome	0.00622	0.0256	CbGbCtD
Meloxicam—CYP3A4—Trimethadione—epilepsy syndrome	0.00597	0.0245	CbGbCtD
Meloxicam—CYP3A4—Felbamate—epilepsy syndrome	0.00597	0.0245	CbGbCtD
Meloxicam—CYP2C8—Valproic Acid—epilepsy syndrome	0.00594	0.0244	CbGbCtD
Meloxicam—CYP2C9—Propofol—epilepsy syndrome	0.0058	0.0239	CbGbCtD
Meloxicam—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00561	0.0231	CbGbCtD
Meloxicam—CYP2C9—Phenobarbital—epilepsy syndrome	0.00554	0.0228	CbGbCtD
Meloxicam—CYP2C9—Diazepam—epilepsy syndrome	0.00525	0.0216	CbGbCtD
Meloxicam—CYP3A4—Clonazepam—epilepsy syndrome	0.00507	0.0209	CbGbCtD
Meloxicam—CYP3A4—Clobazam—epilepsy syndrome	0.00486	0.02	CbGbCtD
Meloxicam—CYP2C9—Valproic Acid—epilepsy syndrome	0.00414	0.017	CbGbCtD
Meloxicam—CYP3A4—Rufinamide—epilepsy syndrome	0.00413	0.017	CbGbCtD
Meloxicam—CYP3A4—Carbamazepine—epilepsy syndrome	0.00403	0.0166	CbGbCtD
Meloxicam—CYP3A4—Primidone—epilepsy syndrome	0.00376	0.0155	CbGbCtD
Meloxicam—CYP3A4—Phenytoin—epilepsy syndrome	0.00361	0.0149	CbGbCtD
Meloxicam—CYP3A4—Propofol—epilepsy syndrome	0.00337	0.0139	CbGbCtD
Meloxicam—CYP3A4—Acetazolamide—epilepsy syndrome	0.00322	0.0133	CbGbCtD
Meloxicam—CYP3A4—Phenobarbital—epilepsy syndrome	0.00322	0.0133	CbGbCtD
Meloxicam—CYP3A4—Midazolam—epilepsy syndrome	0.00318	0.0131	CbGbCtD
Meloxicam—CYP3A4—Diazepam—epilepsy syndrome	0.00305	0.0126	CbGbCtD
Meloxicam—CYP3A4—Zonisamide—epilepsy syndrome	0.00298	0.0123	CbGbCtD
Meloxicam—CYP3A4—Valproic Acid—epilepsy syndrome	0.00241	0.0099	CbGbCtD
Meloxicam—CYP3A4—Topiramate—epilepsy syndrome	0.00217	0.00894	CbGbCtD
Meloxicam—Lornoxicam—PTGS2—epilepsy syndrome	0.00027	0.341	CrCbGaD
Meloxicam—Tenoxicam—PTGS2—epilepsy syndrome	0.00024	0.304	CrCbGaD
Meloxicam—PGD—forebrain—epilepsy syndrome	0.000182	0.0675	CbGeAlD
Meloxicam—PTGS1—ganglion—epilepsy syndrome	0.000182	0.0674	CbGeAlD
Meloxicam—PGD—telencephalon—epilepsy syndrome	0.000168	0.0621	CbGeAlD
Meloxicam—Piroxicam—PTGS2—epilepsy syndrome	0.000149	0.188	CrCbGaD
Meloxicam—Piroxicam—ALB—epilepsy syndrome	0.000132	0.167	CrCbGaD
Meloxicam—PGD—medulla oblongata—epilepsy syndrome	0.000132	0.0488	CbGeAlD
Meloxicam—ABCC4—forebrain—epilepsy syndrome	0.00013	0.048	CbGeAlD
Meloxicam—PGD—midbrain—epilepsy syndrome	0.00012	0.0446	CbGeAlD
Meloxicam—PGD—spinal cord—epilepsy syndrome	0.000117	0.0435	CbGeAlD
Meloxicam—PGD—head—epilepsy syndrome	0.000104	0.0387	CbGeAlD
Meloxicam—PGD—nervous system—epilepsy syndrome	9.89e-05	0.0367	CbGeAlD
Meloxicam—PGD—central nervous system—epilepsy syndrome	9.52e-05	0.0353	CbGeAlD
Meloxicam—PGD—cerebellum—epilepsy syndrome	9.31e-05	0.0345	CbGeAlD
Meloxicam—PTGS1—forebrain—epilepsy syndrome	7.63e-05	0.0283	CbGeAlD
Meloxicam—PGD—brain—epilepsy syndrome	7.56e-05	0.028	CbGeAlD
Meloxicam—ABCC4—head—epilepsy syndrome	7.42e-05	0.0275	CbGeAlD
Meloxicam—PTGS2—forebrain—epilepsy syndrome	7.29e-05	0.027	CbGeAlD
Meloxicam—ABCC4—nervous system—epilepsy syndrome	7.04e-05	0.0261	CbGeAlD
Meloxicam—PTGS1—telencephalon—epilepsy syndrome	7.02e-05	0.026	CbGeAlD
Meloxicam—ABCC4—central nervous system—epilepsy syndrome	6.77e-05	0.0251	CbGeAlD
Meloxicam—PTGS2—telencephalon—epilepsy syndrome	6.71e-05	0.0249	CbGeAlD
Meloxicam—ABCC4—brain—epilepsy syndrome	5.38e-05	0.0199	CbGeAlD
Meloxicam—PTGS2—medulla oblongata—epilepsy syndrome	5.27e-05	0.0195	CbGeAlD
Meloxicam—PTGS1—spinal cord—epilepsy syndrome	4.92e-05	0.0182	CbGeAlD
Meloxicam—PTGS2—midbrain—epilepsy syndrome	4.82e-05	0.0178	CbGeAlD
Meloxicam—PTGS2—spinal cord—epilepsy syndrome	4.7e-05	0.0174	CbGeAlD
Meloxicam—PTGS1—head—epilepsy syndrome	4.37e-05	0.0162	CbGeAlD
Meloxicam—PTGS2—head—epilepsy syndrome	4.18e-05	0.0155	CbGeAlD
Meloxicam—PTGS1—nervous system—epilepsy syndrome	4.14e-05	0.0154	CbGeAlD
Meloxicam—PTGS1—central nervous system—epilepsy syndrome	3.99e-05	0.0148	CbGeAlD
Meloxicam—PTGS2—nervous system—epilepsy syndrome	3.96e-05	0.0147	CbGeAlD
Meloxicam—CYP2C8—brain—epilepsy syndrome	3.9e-05	0.0145	CbGeAlD
Meloxicam—PTGS2—central nervous system—epilepsy syndrome	3.81e-05	0.0141	CbGeAlD
Meloxicam—PTGS2—cerebellum—epilepsy syndrome	3.73e-05	0.0138	CbGeAlD
Meloxicam—CYP3A4—nervous system—epilepsy syndrome	3.46e-05	0.0128	CbGeAlD
Meloxicam—CYP3A4—central nervous system—epilepsy syndrome	3.33e-05	0.0123	CbGeAlD
Meloxicam—PTGS1—brain—epilepsy syndrome	3.17e-05	0.0117	CbGeAlD
Meloxicam—PTGS2—brain—epilepsy syndrome	3.03e-05	0.0112	CbGeAlD
Meloxicam—Ill-defined disorder—Gabapentin—epilepsy syndrome	2.29e-05	0.000206	CcSEcCtD
Meloxicam—Dizziness—Zonisamide—epilepsy syndrome	2.29e-05	0.000206	CcSEcCtD
Meloxicam—Headache—Diazepam—epilepsy syndrome	2.29e-05	0.000206	CcSEcCtD
Meloxicam—Anxiety—Pregabalin—epilepsy syndrome	2.29e-05	0.000205	CcSEcCtD
Meloxicam—Diarrhoea—Clonazepam—epilepsy syndrome	2.29e-05	0.000205	CcSEcCtD
Meloxicam—Anaemia—Gabapentin—epilepsy syndrome	2.28e-05	0.000205	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.28e-05	0.000205	CcSEcCtD
Meloxicam—Hypotension—Valproic Acid—epilepsy syndrome	2.27e-05	0.000204	CcSEcCtD
Meloxicam—Asthenia—Carbamazepine—epilepsy syndrome	2.27e-05	0.000204	CcSEcCtD
Meloxicam—Diarrhoea—Phenytoin—epilepsy syndrome	2.27e-05	0.000204	CcSEcCtD
Meloxicam—Discomfort—Pregabalin—epilepsy syndrome	2.27e-05	0.000204	CcSEcCtD
Meloxicam—Nausea—Fosphenytoin—epilepsy syndrome	2.27e-05	0.000203	CcSEcCtD
Meloxicam—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.26e-05	0.000203	CcSEcCtD
Meloxicam—Erythema multiforme—Topiramate—epilepsy syndrome	2.26e-05	0.000203	CcSEcCtD
Meloxicam—Angioedema—Gabapentin—epilepsy syndrome	2.26e-05	0.000203	CcSEcCtD
Meloxicam—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.26e-05	0.000203	CcSEcCtD
Meloxicam—Vomiting—Felbamate—epilepsy syndrome	2.25e-05	0.000202	CcSEcCtD
Meloxicam—Dry mouth—Pregabalin—epilepsy syndrome	2.24e-05	0.000202	CcSEcCtD
Meloxicam—Pruritus—Carbamazepine—epilepsy syndrome	2.24e-05	0.000201	CcSEcCtD
Meloxicam—Rash—Felbamate—epilepsy syndrome	2.23e-05	0.000201	CcSEcCtD
Meloxicam—Eye disorder—Topiramate—epilepsy syndrome	2.23e-05	0.0002	CcSEcCtD
Meloxicam—Dermatitis—Felbamate—epilepsy syndrome	2.23e-05	0.0002	CcSEcCtD
Meloxicam—Malaise—Gabapentin—epilepsy syndrome	2.23e-05	0.0002	CcSEcCtD
Meloxicam—Tinnitus—Topiramate—epilepsy syndrome	2.23e-05	0.0002	CcSEcCtD
Meloxicam—Vertigo—Gabapentin—epilepsy syndrome	2.22e-05	0.000199	CcSEcCtD
Meloxicam—Headache—Felbamate—epilepsy syndrome	2.22e-05	0.000199	CcSEcCtD
Meloxicam—Confusional state—Pregabalin—epilepsy syndrome	2.22e-05	0.000199	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.22e-05	0.000199	CcSEcCtD
Meloxicam—Cardiac disorder—Topiramate—epilepsy syndrome	2.22e-05	0.000199	CcSEcCtD
Meloxicam—Flushing—Topiramate—epilepsy syndrome	2.22e-05	0.000199	CcSEcCtD
Meloxicam—Syncope—Gabapentin—epilepsy syndrome	2.22e-05	0.000199	CcSEcCtD
Meloxicam—Leukopenia—Gabapentin—epilepsy syndrome	2.21e-05	0.000199	CcSEcCtD
Meloxicam—Dizziness—Clonazepam—epilepsy syndrome	2.21e-05	0.000198	CcSEcCtD
Meloxicam—Nausea—Vigabatrin—epilepsy syndrome	2.21e-05	0.000198	CcSEcCtD
Meloxicam—Vomiting—Zonisamide—epilepsy syndrome	2.2e-05	0.000198	CcSEcCtD
Meloxicam—Insomnia—Valproic Acid—epilepsy syndrome	2.2e-05	0.000198	CcSEcCtD
Meloxicam—Oedema—Pregabalin—epilepsy syndrome	2.2e-05	0.000198	CcSEcCtD
Meloxicam—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.2e-05	0.000198	CcSEcCtD
Meloxicam—Asthenia—Lamotrigine—epilepsy syndrome	2.2e-05	0.000197	CcSEcCtD
Meloxicam—Dizziness—Phenytoin—epilepsy syndrome	2.19e-05	0.000197	CcSEcCtD
Meloxicam—Rash—Zonisamide—epilepsy syndrome	2.19e-05	0.000196	CcSEcCtD
Meloxicam—Infection—Pregabalin—epilepsy syndrome	2.19e-05	0.000196	CcSEcCtD
Meloxicam—Paraesthesia—Valproic Acid—epilepsy syndrome	2.18e-05	0.000196	CcSEcCtD
Meloxicam—Palpitations—Gabapentin—epilepsy syndrome	2.18e-05	0.000196	CcSEcCtD
Meloxicam—Dermatitis—Zonisamide—epilepsy syndrome	2.18e-05	0.000196	CcSEcCtD
Meloxicam—Dizziness—Oxcarbazepine—epilepsy syndrome	2.18e-05	0.000196	CcSEcCtD
Meloxicam—Nausea—Diazepam—epilepsy syndrome	2.17e-05	0.000195	CcSEcCtD
Meloxicam—Loss of consciousness—Gabapentin—epilepsy syndrome	2.17e-05	0.000195	CcSEcCtD
Meloxicam—Headache—Zonisamide—epilepsy syndrome	2.17e-05	0.000195	CcSEcCtD
Meloxicam—Dyspnoea—Valproic Acid—epilepsy syndrome	2.17e-05	0.000195	CcSEcCtD
Meloxicam—Diarrhoea—Carbamazepine—epilepsy syndrome	2.17e-05	0.000195	CcSEcCtD
Meloxicam—Angiopathy—Topiramate—epilepsy syndrome	2.17e-05	0.000195	CcSEcCtD
Meloxicam—Pruritus—Lamotrigine—epilepsy syndrome	2.17e-05	0.000195	CcSEcCtD
Meloxicam—Shock—Pregabalin—epilepsy syndrome	2.16e-05	0.000194	CcSEcCtD
Meloxicam—Somnolence—Valproic Acid—epilepsy syndrome	2.16e-05	0.000194	CcSEcCtD
Meloxicam—Immune system disorder—Topiramate—epilepsy syndrome	2.16e-05	0.000194	CcSEcCtD
Meloxicam—Nervous system disorder—Pregabalin—epilepsy syndrome	2.16e-05	0.000194	CcSEcCtD
Meloxicam—Cough—Gabapentin—epilepsy syndrome	2.16e-05	0.000194	CcSEcCtD
Meloxicam—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.15e-05	0.000193	CcSEcCtD
Meloxicam—Mediastinal disorder—Topiramate—epilepsy syndrome	2.15e-05	0.000193	CcSEcCtD
Meloxicam—Tachycardia—Pregabalin—epilepsy syndrome	2.15e-05	0.000193	CcSEcCtD
Meloxicam—Dyspepsia—Valproic Acid—epilepsy syndrome	2.14e-05	0.000192	CcSEcCtD
Meloxicam—Convulsion—Gabapentin—epilepsy syndrome	2.14e-05	0.000192	CcSEcCtD
Meloxicam—Skin disorder—Pregabalin—epilepsy syndrome	2.14e-05	0.000192	CcSEcCtD
Meloxicam—Hypertension—Gabapentin—epilepsy syndrome	2.13e-05	0.000192	CcSEcCtD
Meloxicam—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.13e-05	0.000191	CcSEcCtD
Meloxicam—Vomiting—Clonazepam—epilepsy syndrome	2.12e-05	0.000191	CcSEcCtD
Meloxicam—Decreased appetite—Valproic Acid—epilepsy syndrome	2.12e-05	0.00019	CcSEcCtD
Meloxicam—Alopecia—Topiramate—epilepsy syndrome	2.11e-05	0.00019	CcSEcCtD
Meloxicam—Vomiting—Phenytoin—epilepsy syndrome	2.11e-05	0.00019	CcSEcCtD
Meloxicam—Rash—Clonazepam—epilepsy syndrome	2.11e-05	0.000189	CcSEcCtD
Meloxicam—Dermatitis—Clonazepam—epilepsy syndrome	2.11e-05	0.000189	CcSEcCtD
Meloxicam—Arthralgia—Gabapentin—epilepsy syndrome	2.1e-05	0.000189	CcSEcCtD
Meloxicam—Myalgia—Gabapentin—epilepsy syndrome	2.1e-05	0.000189	CcSEcCtD
Meloxicam—Nausea—Felbamate—epilepsy syndrome	2.1e-05	0.000189	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.1e-05	0.000189	CcSEcCtD
Meloxicam—Vomiting—Oxcarbazepine—epilepsy syndrome	2.1e-05	0.000189	CcSEcCtD
Meloxicam—Fatigue—Valproic Acid—epilepsy syndrome	2.1e-05	0.000188	CcSEcCtD
Meloxicam—Anxiety—Gabapentin—epilepsy syndrome	2.1e-05	0.000188	CcSEcCtD
Meloxicam—Dizziness—Carbamazepine—epilepsy syndrome	2.1e-05	0.000188	CcSEcCtD
Meloxicam—Diarrhoea—Lamotrigine—epilepsy syndrome	2.1e-05	0.000188	CcSEcCtD
Meloxicam—Headache—Clonazepam—epilepsy syndrome	2.09e-05	0.000188	CcSEcCtD
Meloxicam—Rash—Phenytoin—epilepsy syndrome	2.09e-05	0.000188	CcSEcCtD
Meloxicam—Mental disorder—Topiramate—epilepsy syndrome	2.09e-05	0.000188	CcSEcCtD
Meloxicam—Dermatitis—Phenytoin—epilepsy syndrome	2.09e-05	0.000188	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.09e-05	0.000188	CcSEcCtD
Meloxicam—Rash—Oxcarbazepine—epilepsy syndrome	2.08e-05	0.000187	CcSEcCtD
Meloxicam—Pain—Valproic Acid—epilepsy syndrome	2.08e-05	0.000187	CcSEcCtD
Meloxicam—Constipation—Valproic Acid—epilepsy syndrome	2.08e-05	0.000187	CcSEcCtD
Meloxicam—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.08e-05	0.000187	CcSEcCtD
Meloxicam—Headache—Phenytoin—epilepsy syndrome	2.08e-05	0.000187	CcSEcCtD
Meloxicam—Malnutrition—Topiramate—epilepsy syndrome	2.08e-05	0.000187	CcSEcCtD
Meloxicam—Erythema—Topiramate—epilepsy syndrome	2.08e-05	0.000187	CcSEcCtD
Meloxicam—Discomfort—Gabapentin—epilepsy syndrome	2.08e-05	0.000187	CcSEcCtD
Meloxicam—Headache—Oxcarbazepine—epilepsy syndrome	2.07e-05	0.000186	CcSEcCtD
Meloxicam—Nausea—Zonisamide—epilepsy syndrome	2.06e-05	0.000185	CcSEcCtD
Meloxicam—Dry mouth—Gabapentin—epilepsy syndrome	2.06e-05	0.000185	CcSEcCtD
Meloxicam—Hypotension—Pregabalin—epilepsy syndrome	2.06e-05	0.000185	CcSEcCtD
Meloxicam—Flatulence—Topiramate—epilepsy syndrome	2.05e-05	0.000184	CcSEcCtD
Meloxicam—Tension—Topiramate—epilepsy syndrome	2.04e-05	0.000183	CcSEcCtD
Meloxicam—Dysgeusia—Topiramate—epilepsy syndrome	2.04e-05	0.000183	CcSEcCtD
Meloxicam—Confusional state—Gabapentin—epilepsy syndrome	2.03e-05	0.000183	CcSEcCtD
Meloxicam—Dizziness—Lamotrigine—epilepsy syndrome	2.02e-05	0.000182	CcSEcCtD
Meloxicam—Nervousness—Topiramate—epilepsy syndrome	2.02e-05	0.000181	CcSEcCtD
Meloxicam—Oedema—Gabapentin—epilepsy syndrome	2.02e-05	0.000181	CcSEcCtD
Meloxicam—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.02e-05	0.000181	CcSEcCtD
Meloxicam—Vomiting—Carbamazepine—epilepsy syndrome	2.01e-05	0.000181	CcSEcCtD
Meloxicam—Back pain—Topiramate—epilepsy syndrome	2.01e-05	0.000181	CcSEcCtD
Meloxicam—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.01e-05	0.00018	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2e-05	0.00018	CcSEcCtD
Meloxicam—Infection—Gabapentin—epilepsy syndrome	2e-05	0.00018	CcSEcCtD
Meloxicam—Muscle spasms—Topiramate—epilepsy syndrome	2e-05	0.00018	CcSEcCtD
Meloxicam—Rash—Carbamazepine—epilepsy syndrome	2e-05	0.000179	CcSEcCtD
Meloxicam—Dermatitis—Carbamazepine—epilepsy syndrome	2e-05	0.000179	CcSEcCtD
Meloxicam—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.99e-05	0.000179	CcSEcCtD
Meloxicam—Insomnia—Pregabalin—epilepsy syndrome	1.99e-05	0.000179	CcSEcCtD
Meloxicam—Nausea—Clonazepam—epilepsy syndrome	1.98e-05	0.000178	CcSEcCtD
Meloxicam—Headache—Carbamazepine—epilepsy syndrome	1.98e-05	0.000178	CcSEcCtD
Meloxicam—Shock—Gabapentin—epilepsy syndrome	1.98e-05	0.000178	CcSEcCtD
Meloxicam—Nervous system disorder—Gabapentin—epilepsy syndrome	1.98e-05	0.000178	CcSEcCtD
Meloxicam—Paraesthesia—Pregabalin—epilepsy syndrome	1.98e-05	0.000177	CcSEcCtD
Meloxicam—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.98e-05	0.000177	CcSEcCtD
Meloxicam—Nausea—Phenytoin—epilepsy syndrome	1.97e-05	0.000177	CcSEcCtD
Meloxicam—Tachycardia—Gabapentin—epilepsy syndrome	1.97e-05	0.000177	CcSEcCtD
Meloxicam—Dyspnoea—Pregabalin—epilepsy syndrome	1.96e-05	0.000176	CcSEcCtD
Meloxicam—Nausea—Oxcarbazepine—epilepsy syndrome	1.96e-05	0.000176	CcSEcCtD
Meloxicam—Vision blurred—Topiramate—epilepsy syndrome	1.96e-05	0.000176	CcSEcCtD
Meloxicam—Skin disorder—Gabapentin—epilepsy syndrome	1.96e-05	0.000176	CcSEcCtD
Meloxicam—Somnolence—Pregabalin—epilepsy syndrome	1.96e-05	0.000176	CcSEcCtD
Meloxicam—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.95e-05	0.000175	CcSEcCtD
Meloxicam—Tremor—Topiramate—epilepsy syndrome	1.95e-05	0.000175	CcSEcCtD
Meloxicam—Vomiting—Lamotrigine—epilepsy syndrome	1.95e-05	0.000175	CcSEcCtD
Meloxicam—Urticaria—Valproic Acid—epilepsy syndrome	1.93e-05	0.000174	CcSEcCtD
Meloxicam—Rash—Lamotrigine—epilepsy syndrome	1.93e-05	0.000173	CcSEcCtD
Meloxicam—Ill-defined disorder—Topiramate—epilepsy syndrome	1.93e-05	0.000173	CcSEcCtD
Meloxicam—Dermatitis—Lamotrigine—epilepsy syndrome	1.93e-05	0.000173	CcSEcCtD
Meloxicam—Abdominal pain—Valproic Acid—epilepsy syndrome	1.92e-05	0.000173	CcSEcCtD
Meloxicam—Body temperature increased—Valproic Acid—epilepsy syndrome	1.92e-05	0.000173	CcSEcCtD
Meloxicam—Anaemia—Topiramate—epilepsy syndrome	1.92e-05	0.000173	CcSEcCtD
Meloxicam—Headache—Lamotrigine—epilepsy syndrome	1.92e-05	0.000172	CcSEcCtD
Meloxicam—Decreased appetite—Pregabalin—epilepsy syndrome	1.91e-05	0.000172	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.9e-05	0.000171	CcSEcCtD
Meloxicam—Fatigue—Pregabalin—epilepsy syndrome	1.9e-05	0.00017	CcSEcCtD
Meloxicam—Hypotension—Gabapentin—epilepsy syndrome	1.88e-05	0.000169	CcSEcCtD
Meloxicam—Nausea—Carbamazepine—epilepsy syndrome	1.88e-05	0.000169	CcSEcCtD
Meloxicam—Pain—Pregabalin—epilepsy syndrome	1.88e-05	0.000169	CcSEcCtD
Meloxicam—Constipation—Pregabalin—epilepsy syndrome	1.88e-05	0.000169	CcSEcCtD
Meloxicam—Malaise—Topiramate—epilepsy syndrome	1.88e-05	0.000168	CcSEcCtD
Meloxicam—Vertigo—Topiramate—epilepsy syndrome	1.87e-05	0.000168	CcSEcCtD
Meloxicam—Syncope—Topiramate—epilepsy syndrome	1.86e-05	0.000167	CcSEcCtD
Meloxicam—Leukopenia—Topiramate—epilepsy syndrome	1.86e-05	0.000167	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.84e-05	0.000165	CcSEcCtD
Meloxicam—Palpitations—Topiramate—epilepsy syndrome	1.84e-05	0.000165	CcSEcCtD
Meloxicam—Loss of consciousness—Topiramate—epilepsy syndrome	1.83e-05	0.000164	CcSEcCtD
Meloxicam—Insomnia—Gabapentin—epilepsy syndrome	1.82e-05	0.000164	CcSEcCtD
Meloxicam—Nausea—Lamotrigine—epilepsy syndrome	1.82e-05	0.000163	CcSEcCtD
Meloxicam—Cough—Topiramate—epilepsy syndrome	1.81e-05	0.000163	CcSEcCtD
Meloxicam—Feeling abnormal—Pregabalin—epilepsy syndrome	1.81e-05	0.000163	CcSEcCtD
Meloxicam—Paraesthesia—Gabapentin—epilepsy syndrome	1.81e-05	0.000163	CcSEcCtD
Meloxicam—Convulsion—Topiramate—epilepsy syndrome	1.8e-05	0.000162	CcSEcCtD
Meloxicam—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.8e-05	0.000162	CcSEcCtD
Meloxicam—Dyspnoea—Gabapentin—epilepsy syndrome	1.8e-05	0.000161	CcSEcCtD
Meloxicam—Hypertension—Topiramate—epilepsy syndrome	1.8e-05	0.000161	CcSEcCtD
Meloxicam—Somnolence—Gabapentin—epilepsy syndrome	1.79e-05	0.000161	CcSEcCtD
Meloxicam—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.79e-05	0.000161	CcSEcCtD
Meloxicam—Dyspepsia—Gabapentin—epilepsy syndrome	1.78e-05	0.000159	CcSEcCtD
Meloxicam—Arthralgia—Topiramate—epilepsy syndrome	1.77e-05	0.000159	CcSEcCtD
Meloxicam—Myalgia—Topiramate—epilepsy syndrome	1.77e-05	0.000159	CcSEcCtD
Meloxicam—Anxiety—Topiramate—epilepsy syndrome	1.76e-05	0.000158	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.76e-05	0.000158	CcSEcCtD
Meloxicam—Decreased appetite—Gabapentin—epilepsy syndrome	1.75e-05	0.000157	CcSEcCtD
Meloxicam—Discomfort—Topiramate—epilepsy syndrome	1.75e-05	0.000157	CcSEcCtD
Meloxicam—Urticaria—Pregabalin—epilepsy syndrome	1.75e-05	0.000157	CcSEcCtD
Meloxicam—Asthenia—Valproic Acid—epilepsy syndrome	1.75e-05	0.000157	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.74e-05	0.000156	CcSEcCtD
Meloxicam—Fatigue—Gabapentin—epilepsy syndrome	1.74e-05	0.000156	CcSEcCtD
Meloxicam—Body temperature increased—Pregabalin—epilepsy syndrome	1.74e-05	0.000156	CcSEcCtD
Meloxicam—Abdominal pain—Pregabalin—epilepsy syndrome	1.74e-05	0.000156	CcSEcCtD
Meloxicam—Dry mouth—Topiramate—epilepsy syndrome	1.73e-05	0.000155	CcSEcCtD
Meloxicam—Pain—Gabapentin—epilepsy syndrome	1.72e-05	0.000155	CcSEcCtD
Meloxicam—Constipation—Gabapentin—epilepsy syndrome	1.72e-05	0.000155	CcSEcCtD
Meloxicam—Pruritus—Valproic Acid—epilepsy syndrome	1.72e-05	0.000155	CcSEcCtD
Meloxicam—Confusional state—Topiramate—epilepsy syndrome	1.71e-05	0.000154	CcSEcCtD
Meloxicam—Oedema—Topiramate—epilepsy syndrome	1.7e-05	0.000152	CcSEcCtD
Meloxicam—Infection—Topiramate—epilepsy syndrome	1.69e-05	0.000151	CcSEcCtD
Meloxicam—Shock—Topiramate—epilepsy syndrome	1.67e-05	0.00015	CcSEcCtD
Meloxicam—Diarrhoea—Valproic Acid—epilepsy syndrome	1.66e-05	0.000149	CcSEcCtD
Meloxicam—Nervous system disorder—Topiramate—epilepsy syndrome	1.66e-05	0.000149	CcSEcCtD
Meloxicam—Feeling abnormal—Gabapentin—epilepsy syndrome	1.66e-05	0.000149	CcSEcCtD
Meloxicam—Thrombocytopenia—Topiramate—epilepsy syndrome	1.66e-05	0.000149	CcSEcCtD
Meloxicam—Tachycardia—Topiramate—epilepsy syndrome	1.66e-05	0.000149	CcSEcCtD
Meloxicam—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.65e-05	0.000148	CcSEcCtD
Meloxicam—Skin disorder—Topiramate—epilepsy syndrome	1.65e-05	0.000148	CcSEcCtD
Meloxicam—Hyperhidrosis—Topiramate—epilepsy syndrome	1.64e-05	0.000147	CcSEcCtD
Meloxicam—Hypersensitivity—Pregabalin—epilepsy syndrome	1.62e-05	0.000146	CcSEcCtD
Meloxicam—Dizziness—Valproic Acid—epilepsy syndrome	1.61e-05	0.000144	CcSEcCtD
Meloxicam—Urticaria—Gabapentin—epilepsy syndrome	1.6e-05	0.000144	CcSEcCtD
Meloxicam—Abdominal pain—Gabapentin—epilepsy syndrome	1.59e-05	0.000143	CcSEcCtD
Meloxicam—Body temperature increased—Gabapentin—epilepsy syndrome	1.59e-05	0.000143	CcSEcCtD
Meloxicam—Hypotension—Topiramate—epilepsy syndrome	1.59e-05	0.000142	CcSEcCtD
Meloxicam—Asthenia—Pregabalin—epilepsy syndrome	1.58e-05	0.000142	CcSEcCtD
Meloxicam—Pruritus—Pregabalin—epilepsy syndrome	1.56e-05	0.00014	CcSEcCtD
Meloxicam—Vomiting—Valproic Acid—epilepsy syndrome	1.55e-05	0.000139	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.55e-05	0.000139	CcSEcCtD
Meloxicam—Insomnia—Topiramate—epilepsy syndrome	1.53e-05	0.000138	CcSEcCtD
Meloxicam—Rash—Valproic Acid—epilepsy syndrome	1.53e-05	0.000138	CcSEcCtD
Meloxicam—Dermatitis—Valproic Acid—epilepsy syndrome	1.53e-05	0.000138	CcSEcCtD
Meloxicam—Headache—Valproic Acid—epilepsy syndrome	1.52e-05	0.000137	CcSEcCtD
Meloxicam—Paraesthesia—Topiramate—epilepsy syndrome	1.52e-05	0.000137	CcSEcCtD
Meloxicam—Dyspnoea—Topiramate—epilepsy syndrome	1.51e-05	0.000136	CcSEcCtD
Meloxicam—Somnolence—Topiramate—epilepsy syndrome	1.51e-05	0.000135	CcSEcCtD
Meloxicam—Diarrhoea—Pregabalin—epilepsy syndrome	1.51e-05	0.000135	CcSEcCtD
Meloxicam—Dyspepsia—Topiramate—epilepsy syndrome	1.49e-05	0.000134	CcSEcCtD
Meloxicam—Hypersensitivity—Gabapentin—epilepsy syndrome	1.49e-05	0.000133	CcSEcCtD
Meloxicam—Decreased appetite—Topiramate—epilepsy syndrome	1.48e-05	0.000132	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.47e-05	0.000132	CcSEcCtD
Meloxicam—Fatigue—Topiramate—epilepsy syndrome	1.46e-05	0.000131	CcSEcCtD
Meloxicam—Dizziness—Pregabalin—epilepsy syndrome	1.45e-05	0.000131	CcSEcCtD
Meloxicam—Pain—Topiramate—epilepsy syndrome	1.45e-05	0.00013	CcSEcCtD
Meloxicam—Constipation—Topiramate—epilepsy syndrome	1.45e-05	0.00013	CcSEcCtD
Meloxicam—Asthenia—Gabapentin—epilepsy syndrome	1.45e-05	0.00013	CcSEcCtD
Meloxicam—Nausea—Valproic Acid—epilepsy syndrome	1.45e-05	0.00013	CcSEcCtD
Meloxicam—Pruritus—Gabapentin—epilepsy syndrome	1.43e-05	0.000128	CcSEcCtD
Meloxicam—Vomiting—Pregabalin—epilepsy syndrome	1.4e-05	0.000126	CcSEcCtD
Meloxicam—Feeling abnormal—Topiramate—epilepsy syndrome	1.4e-05	0.000126	CcSEcCtD
Meloxicam—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.39e-05	0.000125	CcSEcCtD
Meloxicam—Rash—Pregabalin—epilepsy syndrome	1.39e-05	0.000125	CcSEcCtD
Meloxicam—Dermatitis—Pregabalin—epilepsy syndrome	1.39e-05	0.000124	CcSEcCtD
Meloxicam—Diarrhoea—Gabapentin—epilepsy syndrome	1.38e-05	0.000124	CcSEcCtD
Meloxicam—Headache—Pregabalin—epilepsy syndrome	1.38e-05	0.000124	CcSEcCtD
Meloxicam—Urticaria—Topiramate—epilepsy syndrome	1.35e-05	0.000121	CcSEcCtD
Meloxicam—Abdominal pain—Topiramate—epilepsy syndrome	1.34e-05	0.00012	CcSEcCtD
Meloxicam—Body temperature increased—Topiramate—epilepsy syndrome	1.34e-05	0.00012	CcSEcCtD
Meloxicam—Dizziness—Gabapentin—epilepsy syndrome	1.33e-05	0.00012	CcSEcCtD
Meloxicam—Nausea—Pregabalin—epilepsy syndrome	1.31e-05	0.000117	CcSEcCtD
Meloxicam—Vomiting—Gabapentin—epilepsy syndrome	1.28e-05	0.000115	CcSEcCtD
Meloxicam—Rash—Gabapentin—epilepsy syndrome	1.27e-05	0.000114	CcSEcCtD
Meloxicam—Dermatitis—Gabapentin—epilepsy syndrome	1.27e-05	0.000114	CcSEcCtD
Meloxicam—Headache—Gabapentin—epilepsy syndrome	1.26e-05	0.000113	CcSEcCtD
Meloxicam—Hypersensitivity—Topiramate—epilepsy syndrome	1.25e-05	0.000112	CcSEcCtD
Meloxicam—Asthenia—Topiramate—epilepsy syndrome	1.22e-05	0.000109	CcSEcCtD
Meloxicam—Pruritus—Topiramate—epilepsy syndrome	1.2e-05	0.000108	CcSEcCtD
Meloxicam—Nausea—Gabapentin—epilepsy syndrome	1.2e-05	0.000108	CcSEcCtD
Meloxicam—Diarrhoea—Topiramate—epilepsy syndrome	1.16e-05	0.000104	CcSEcCtD
Meloxicam—Dizziness—Topiramate—epilepsy syndrome	1.12e-05	0.000101	CcSEcCtD
Meloxicam—Vomiting—Topiramate—epilepsy syndrome	1.08e-05	9.69e-05	CcSEcCtD
Meloxicam—Rash—Topiramate—epilepsy syndrome	1.07e-05	9.61e-05	CcSEcCtD
Meloxicam—Dermatitis—Topiramate—epilepsy syndrome	1.07e-05	9.6e-05	CcSEcCtD
Meloxicam—Headache—Topiramate—epilepsy syndrome	1.06e-05	9.55e-05	CcSEcCtD
Meloxicam—Nausea—Topiramate—epilepsy syndrome	1.01e-05	9.05e-05	CcSEcCtD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	7.53e-06	0.000277	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALDH7A1—epilepsy syndrome	7.43e-06	0.000273	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CACNA1A—epilepsy syndrome	7.43e-06	0.000273	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—HSD17B4—epilepsy syndrome	7.36e-06	0.00027	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ST3GAL3—epilepsy syndrome	7.27e-06	0.000267	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—COX3—epilepsy syndrome	7.18e-06	0.000264	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ADSL—epilepsy syndrome	7.13e-06	0.000262	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PPP1R3C—epilepsy syndrome	7.11e-06	0.000261	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GBE1—epilepsy syndrome	7.11e-06	0.000261	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—KCNJ11—epilepsy syndrome	7.09e-06	0.00026	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CHRM3—epilepsy syndrome	7.09e-06	0.00026	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PTGS2—epilepsy syndrome	7.04e-06	0.000259	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GLUL—epilepsy syndrome	6.99e-06	0.000257	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	6.95e-06	0.000255	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CACNA1D—epilepsy syndrome	6.86e-06	0.000252	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—ALB—epilepsy syndrome	6.84e-06	0.000251	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	6.82e-06	0.00025	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	6.81e-06	0.00025	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	6.81e-06	0.00025	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PFKL—epilepsy syndrome	6.81e-06	0.00025	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	6.81e-06	0.00025	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	6.81e-06	0.00025	CbGpPWpGaD
Meloxicam—PGD—Disease—SRC—epilepsy syndrome	6.8e-06	0.00025	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	6.74e-06	0.000248	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ASAH1—epilepsy syndrome	6.69e-06	0.000245	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	6.65e-06	0.000244	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	6.64e-06	0.000244	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	6.61e-06	0.000243	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.61e-06	0.000243	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—STXBP1—epilepsy syndrome	6.5e-06	0.000239	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.47e-06	0.000238	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—TXNRD1—epilepsy syndrome	6.42e-06	0.000236	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—NT5E—epilepsy syndrome	6.34e-06	0.000233	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALAD—epilepsy syndrome	6.34e-06	0.000233	CbGpPWpGaD
Meloxicam—PTGS2—Disease—EIF2AK2—epilepsy syndrome	6.32e-06	0.000232	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—AQP1—epilepsy syndrome	6.23e-06	0.000229	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NEU1—epilepsy syndrome	6.23e-06	0.000229	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ATIC—epilepsy syndrome	6.23e-06	0.000229	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—UPB1—epilepsy syndrome	6.23e-06	0.000229	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CACNA1A—epilepsy syndrome	6.05e-06	0.000222	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALDH7A1—epilepsy syndrome	6.05e-06	0.000222	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	5.99e-06	0.00022	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.98e-06	0.00022	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	5.92e-06	0.000217	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—FAR1—epilepsy syndrome	5.92e-06	0.000217	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CERS1—epilepsy syndrome	5.92e-06	0.000217	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ADK—epilepsy syndrome	5.92e-06	0.000217	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PDXK—epilepsy syndrome	5.92e-06	0.000217	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	5.92e-06	0.000217	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ST3GAL3—epilepsy syndrome	5.92e-06	0.000217	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PPIA—epilepsy syndrome	5.85e-06	0.000215	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ADSL—epilepsy syndrome	5.8e-06	0.000213	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	5.79e-06	0.000213	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GBE1—epilepsy syndrome	5.79e-06	0.000213	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ABCG2—epilepsy syndrome	5.78e-06	0.000212	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	5.69e-06	0.000209	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GLUL—epilepsy syndrome	5.69e-06	0.000209	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	5.66e-06	0.000208	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP2C19—epilepsy syndrome	5.64e-06	0.000207	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CHRM3—epilepsy syndrome	5.63e-06	0.000207	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—KCNJ11—epilepsy syndrome	5.63e-06	0.000207	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP11A1—epilepsy syndrome	5.6e-06	0.000206	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—SRC—epilepsy syndrome	5.59e-06	0.000205	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CACNA1D—epilepsy syndrome	5.58e-06	0.000205	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.56e-06	0.000204	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—VEGFA—epilepsy syndrome	5.45e-06	0.0002	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	5.44e-06	0.0002	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GAMT—epilepsy syndrome	5.42e-06	0.000199	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	5.42e-06	0.000199	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	5.42e-06	0.000199	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PNPO—epilepsy syndrome	5.42e-06	0.000199	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	5.29e-06	0.000194	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.25e-06	0.000193	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—TXNRD1—epilepsy syndrome	5.22e-06	0.000192	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NT5E—epilepsy syndrome	5.16e-06	0.000189	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALAD—epilepsy syndrome	5.16e-06	0.000189	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.14e-06	0.000189	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.07e-06	0.000186	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—AQP1—epilepsy syndrome	5.07e-06	0.000186	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP2D6—epilepsy syndrome	5.06e-06	0.000186	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—QDPR—epilepsy syndrome	5.04e-06	0.000185	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CA4—epilepsy syndrome	5.04e-06	0.000185	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	5.02e-06	0.000184	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	4.92e-06	0.000181	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	4.92e-06	0.000181	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.87e-06	0.000179	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	4.82e-06	0.000177	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ADRA2A—epilepsy syndrome	4.81e-06	0.000177	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—BCHE—epilepsy syndrome	4.79e-06	0.000176	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—COX3—epilepsy syndrome	4.74e-06	0.000174	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ADSL—epilepsy syndrome	4.72e-06	0.000173	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GLUL—epilepsy syndrome	4.63e-06	0.00017	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ABCG2—epilepsy syndrome	4.59e-06	0.000169	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	4.58e-06	0.000168	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	4.58e-06	0.000168	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—SLC2A1—epilepsy syndrome	4.57e-06	0.000168	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	4.54e-06	0.000167	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PLCB1—epilepsy syndrome	4.52e-06	0.000166	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—TH—epilepsy syndrome	4.51e-06	0.000165	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	4.49e-06	0.000165	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	4.49e-06	0.000165	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	4.49e-06	0.000165	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	4.49e-06	0.000165	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PFKL—epilepsy syndrome	4.49e-06	0.000165	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	4.47e-06	0.000164	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	4.45e-06	0.000163	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.44e-06	0.000163	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.41e-06	0.000162	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SLC2A1—epilepsy syndrome	4.33e-06	0.000159	CbGpPWpGaD
Meloxicam—PTGS2—Disease—JUNB—epilepsy syndrome	4.3e-06	0.000158	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NOS1—epilepsy syndrome	4.27e-06	0.000157	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.27e-06	0.000157	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	4.25e-06	0.000156	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	4.24e-06	0.000156	CbGpPWpGaD
Meloxicam—PGD—Disease—AKT1—epilepsy syndrome	4.23e-06	0.000155	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.18e-06	0.000154	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—AQP1—epilepsy syndrome	4.12e-06	0.000151	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ATIC—epilepsy syndrome	4.11e-06	0.000151	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NEU1—epilepsy syndrome	4.11e-06	0.000151	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—UPB1—epilepsy syndrome	4.11e-06	0.000151	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HBEGF—epilepsy syndrome	4.07e-06	0.00015	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.02e-06	0.000148	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	4.01e-06	0.000147	CbGpPWpGaD
Meloxicam—PTGS2—Disease—AKT3—epilepsy syndrome	4e-06	0.000147	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.96e-06	0.000145	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	3.95e-06	0.000145	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ADAM10—epilepsy syndrome	3.91e-06	0.000143	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	3.82e-06	0.00014	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GBE1—epilepsy syndrome	3.82e-06	0.00014	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	3.82e-06	0.00014	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—BCHE—epilepsy syndrome	3.8e-06	0.00014	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—HMOX1—epilepsy syndrome	3.76e-06	0.000138	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	3.74e-06	0.000137	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	3.73e-06	0.000137	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	3.73e-06	0.000137	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CAT—epilepsy syndrome	3.71e-06	0.000136	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CDC42—epilepsy syndrome	3.65e-06	0.000134	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	3.64e-06	0.000134	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	3.63e-06	0.000133	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	3.62e-06	0.000133	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ABCB1—epilepsy syndrome	3.61e-06	0.000133	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.59e-06	0.000132	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PLCB1—epilepsy syndrome	3.59e-06	0.000132	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	3.59e-06	0.000132	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—TH—epilepsy syndrome	3.58e-06	0.000131	CbGpPWpGaD
Meloxicam—PGD—Metabolism—AKT1—epilepsy syndrome	3.54e-06	0.00013	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	3.49e-06	0.000128	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—AKT1—epilepsy syndrome	3.48e-06	0.000128	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.47e-06	0.000128	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.4e-06	0.000125	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALAD—epilepsy syndrome	3.4e-06	0.000125	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NT5E—epilepsy syndrome	3.4e-06	0.000125	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GPX1—epilepsy syndrome	3.36e-06	0.000123	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HES1—epilepsy syndrome	3.34e-06	0.000123	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.28e-06	0.00012	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	3.27e-06	0.00012	CbGpPWpGaD
Meloxicam—PTGS2—Disease—FYN—epilepsy syndrome	3.25e-06	0.000119	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.25e-06	0.000119	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.25e-06	0.000119	CbGpPWpGaD
Meloxicam—PTGS2—Disease—H2AFX—epilepsy syndrome	3.24e-06	0.000119	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.18e-06	0.000117	CbGpPWpGaD
Meloxicam—PTGS2—Disease—YWHAZ—epilepsy syndrome	3.12e-06	0.000115	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.11e-06	0.000114	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	3.11e-06	0.000114	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—BCHE—epilepsy syndrome	3.1e-06	0.000114	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.05e-06	0.000112	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	3.04e-06	0.000112	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CCR5—epilepsy syndrome	3e-06	0.00011	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3e-06	0.00011	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—HMOX1—epilepsy syndrome	2.99e-06	0.00011	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	2.96e-06	0.000109	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	2.95e-06	0.000108	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CAT—epilepsy syndrome	2.95e-06	0.000108	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	2.94e-06	0.000108	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—AGT—epilepsy syndrome	2.94e-06	0.000108	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.92e-06	0.000107	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	2.92e-06	0.000107	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—TH—epilepsy syndrome	2.91e-06	0.000107	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—APOE—epilepsy syndrome	2.88e-06	0.000106	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ABCB1—epilepsy syndrome	2.87e-06	0.000105	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.87e-06	0.000105	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.8e-06	0.000103	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TSC2—epilepsy syndrome	2.79e-06	0.000103	CbGpPWpGaD
Meloxicam—PTGS2—Disease—APOE—epilepsy syndrome	2.73e-06	0.0001	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.72e-06	9.99e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.67e-06	9.79e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GPX1—epilepsy syndrome	2.66e-06	9.78e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	2.66e-06	9.76e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IL6ST—epilepsy syndrome	2.57e-06	9.42e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NOS2—epilepsy syndrome	2.55e-06	9.35e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	2.53e-06	9.29e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2.52e-06	9.25e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—POMC—epilepsy syndrome	2.48e-06	9.09e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.46e-06	9.03e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.46e-06	9.03e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	2.43e-06	8.92e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	2.4e-06	8.82e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CAT—epilepsy syndrome	2.4e-06	8.8e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	2.38e-06	8.73e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—TH—epilepsy syndrome	2.37e-06	8.7e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—AGT—epilepsy syndrome	2.34e-06	8.58e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.33e-06	8.56e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	2.33e-06	8.56e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—APOE—epilepsy syndrome	2.29e-06	8.4e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ALB—epilepsy syndrome	2.26e-06	8.29e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GPX1—epilepsy syndrome	2.17e-06	7.96e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—FGF2—epilepsy syndrome	2.08e-06	7.62e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.01e-06	7.36e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.98e-06	7.26e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTGS2—epilepsy syndrome	1.98e-06	7.25e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—POMC—epilepsy syndrome	1.97e-06	7.22e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.95e-06	7.17e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.95e-06	7.16e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.94e-06	7.13e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—AGT—epilepsy syndrome	1.9e-06	6.98e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.9e-06	6.97e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MTOR—epilepsy syndrome	1.89e-06	6.94e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—APOE—epilepsy syndrome	1.86e-06	6.84e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALB—epilepsy syndrome	1.79e-06	6.58e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.76e-06	6.48e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.75e-06	6.43e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.67e-06	6.13e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.66e-06	6.1e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—POMC—epilepsy syndrome	1.6e-06	5.87e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.59e-06	5.82e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.57e-06	5.76e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—TH—epilepsy syndrome	1.56e-06	5.74e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.55e-06	5.68e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.52e-06	5.56e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SRC—epilepsy syndrome	1.51e-06	5.56e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.46e-06	5.35e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.3e-06	4.79e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.3e-06	4.78e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.29e-06	4.72e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.28e-06	4.68e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.25e-06	4.59e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.19e-06	4.36e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.16e-06	4.27e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.04e-06	3.81e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.02e-06	3.75e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—APOE—epilepsy syndrome	1e-06	3.67e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—AKT1—epilepsy syndrome	9.93e-07	3.65e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—AKT1—epilepsy syndrome	9.41e-07	3.46e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—POMC—epilepsy syndrome	8.59e-07	3.15e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—AKT1—epilepsy syndrome	7.88e-07	2.89e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALB—epilepsy syndrome	7.83e-07	2.87e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	6.85e-07	2.51e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—AKT1—epilepsy syndrome	6.41e-07	2.35e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—AKT1—epilepsy syndrome	5.22e-07	1.92e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—AKT1—epilepsy syndrome	3.44e-07	1.26e-05	CbGpPWpGaD
